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NeurodegenerationLeishmaniasis is a parasitosis caused by several species of the genus Leishmania, an obligate intramacro-
phagic parasite. Although neurologic symptoms have been observed in human cases of leishmaniasis, the
manifestation of neurodegenerative processes is poorly studied. The aim of the present work was to
investigate if peripheral infection of BALB/c mice with Leishmania amazonensis affects tau phosphoryla-
tion and RAGE protein content in the brain, which represent biochemical markers of neurodegenerative
processes observed in diseases with a pro-inﬂammatory component, including Alzheimer’s disease and
Down syndrome. Four months after a single right hind footpad subcutaneous injection of L. amazonensis,
the brain cortex of BALB/c mice was isolated. Western blot analysis indicated an increase in tau phos-
phorylation (Ser396) and RAGE immunocontent in infected animals. Brain tissue TNF-a, IL-1b, and IL-6
levels were not different from control animals; however, increased protein carbonylation, decreased
IFN-c levels and impairment in antioxidant defenses were detected. Systemic antioxidant treatment
(NAC 20 mg/kg, i.p.) inhibited tau phosphorylation and recovered IFN-c levels. These data, altogether,
indicate an association between impaired redox state, tau phosphorylation and RAGE up-regulation in
the brain cortex of animals infected with L. amazonensis. In this context, it is possible that neurologic
symptoms associated to chronic leishmaniasis are associated to disruptions in the homeostasis of CNS
proteins, such as tau and RAGE, as consequence of oxidative stress. This is the ﬁrst demonstration of alter-
ations in biochemical parameters of neurodegeneration in an experimental model of Leishmania infection.
 2014 Elsevier Inc. All rights reserved.1. Introduction
Leishmaniasis is a parasitosis caused by several species of the
genus Leishmania, an obligate intramacrophagic parasite. Endemic
leishmaniasis transmission occurs in at least 98 countries (Alvar
et al., 2012). There are three main human syndromes caused by
Leishmania: cutaneous disease, the least severe form of disease;
mucocutaneous disease, which can be due the extension or metas-
tasis of local skin lesions; and visceral leishmaniasis, also known as
Kala-azar, the most severe form (Desjeux, 2004). The outcome ofeach is determined by the species of infecting parasite and the
genetic susceptibility of the host (McGwire and Satoskar, 2013).
Leishmania amazonensis causes different diseases depending on
the host and parasitic virulence factors (Souza et al., 2011). Com-
monly, L. amazonensis infection is more associated to cutaneous
leishmaniasis (Murray et al., 2005), but parasites have been also
isolated from patients with the entire spectrum of the disease,
including localized and diffuse cutaneous lesions, mucosal and vis-
ceral leishmaniasis (Barral et al., 1991). Recently, L. amazonensis
was also associated with disseminate cutaneous leishmaniasis, an
intermediate clinical form (David and Craft, 2009).
Although neurologic symptoms have been largely observed in
human cases of the disease, the manifestation of degenerative
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leishmaniasis is poorly studied. Cutaneous leishmaniasis is known
to cause a peripheral neuropathy by direct or close parasite
involvement with the nerve or nerve sheath (Petersen and
Greenlee, 2011). In this form of the disease, parasites in the skin
and draining lymph nodes are thought to cause an endocrine
imbalance as a consequence of cytokines action on the CNS (de
Moura et al., 2005). More recently, patients with cutaneous
leishmaniasis were reported to exhibit an immune–endocrine
imbalance with reduction of plasma levels of dehydroepiandros-
terone-S, prolactin and testosterone (Baccan et al., 2011). Together
with the observation that L. amazonensis may cross the blood–
brain barrier and induce signiﬁcant pathologic changes in the
CNS (Abreu-Silva et al., 2003), these data indicate that relevant
neurodegenerative processes may occur in the course of
leishmaniasis.
The microtubule-stabilizing protein tau is mainly expressed in
central nervous system (CNS) neurons and is essential for axon
architecture and synaptic function. Initially, the aberrant
hyperphosphorylation of tau was observed to be associated with
the formation of neurotoxic histological structures in the CNS
known as neuroﬁbrillary tangles, characteristic of Alzheimer’s dis-
ease (AD) (Sonnen et al., 2008). Later, tau hyperphosphorylation
was detected in at least twenty-two different CNS related patholo-
gies, including prionic diseases, amyotrophic lateral sclerosis and
Down’s syndrome (Spires-Jones et al., 2009). These conditions have
been referred to as ‘‘tauopathies’’, in which tau aberrant phosphor-
ylation is thought to exert a causative role in synapse impairment
and progression of neuronal cell death. Although the molecular
detailing of the steps coupling tau aberrant phosphorylation and
neuronal death are currently not completely understood, it is clear
that disruption of tau homeostasis is associated with an impair-
ment of neural circuits and cognitive deﬁcits (Gendron and
Petrucelli, 2009).
The receptor for advanced glycation endproducts (RAGE) is a
multiligand membrane receptor that exerts crucial roles in the
development of chronic inﬂammatory processes (Srikanth et al.,
2011). RAGE was initially observed to be associated with late dia-
betic complications, where the accumulation of advanced glycation
endproducts (AGE) on the endothelial surface triggers its expres-
sion and activation. Further studies have characterized RAGE as a
damage-associated molecular pattern (DAMP) receptor, as other
molecules with pro-inﬂammatory and pro-apoptotic activities
were observed to act as RAGE ligands (Coughlan et al., 2007). These
include the extracellular forms of HMGB1 and members of the
S100/calgranulin family, such as S100B and S100A7 (Bopp et al.,
2008; Leclerc et al., 2007). RAGE activation induces the expression
of pro-inﬂammatory cytokines and NADPH oxidase activation,
which in turn stimulate reactive species (RS) production, causing
oxidative damage to biomolecules and sustaining local inﬂamma-
tion and tissue damage (Maczurek et al., 2008). In the brain, a
prominent role of RAGE in the contribution to neurodegenerative
processes has been emerging since the earlier observations that
the b-amyloid peptide function as a RAGE ligand (Arancio et al.,
2004; Du Yan et al., 1997). Since then, extensive data have been
indicating a key role for RAGE in the chronic pro-inﬂammatory axis
responsible for the progression of neuronal death observed in AD
(Yan et al., 2009). On the other hand, the involvement of RAGE in
other neuroinﬂammatory states potentially associated with neuro-
degeneration is poorly studied. In the present work, we investi-
gated the phosphorylation of tau and the modulation of the
immunocontent of RAGE in the brain cortex of BALB/c mice
infected with L. amazonensis. We also analyzed oxidative stress
and inﬂammatory parameters in order to study the possible rela-
tionship of RS production and inﬂammation in the modulation of
neurodegeneration parameters in leishmaniasis.2. Materials and methods
2.1. Chemicals
Glycine, H2O2 (hydrogen peroxide), catalase (CAT, EC 1.11.1.6),
superoxide dismutase (SOD, EC 1.15.1.1), thiobarbituric acid,
epinephrine, AAPH (2,20-azobis[2-methylpropionamidine]dihydro-
chloride), trichloroacetic acid (TCA), 2,4-dinitrophenylhydrazine
(DNPH), 5,50-dithionitrobis 2-nitrobenzoic acid (DTNB), Bile salts,
sodium dodecyl sulfate, DNP polyclonal antibody and monoclonal
TNF-a antibody were purchased from Sigma–Aldrich(St. Louis,
USA). Electrophoresis and immunoblot reagents were from Bio-
Rad (Hercules, USA), GE Healthcare Brazilian Headquarter (São
Paulo, Brazil) and Sigma–Aldrich. RAGE polyclonal antibody, phos-
phorylated tau polyclonal antibody, total tau polyclonal antibody,
b-actin polyclonal antibody, IL-1b polyclonal antibody and
anti-rabbit immunoglobulin linked to peroxidase were from Cell
Signalling technology(Beverly, USA). ELISA microplates were from
Greiner Bio-One (Monroe, USA) and ELISA TMB spectrophotometric
detection kit was from BD Biosciences (San Diego, USA). Immuno-
blot chemiluminescence detection was carried out with the West
Pico detection kit from Thermo Scientiﬁc Pierce Protein Biology
Products (Rockford, USA). MilliQ-puriﬁed H2O was used for
preparing solutions. All other reagents used in this study were of
analytical or HPLC grade.
2.2. Ethics statement
All experimental procedures were performed in accordance
with the National Institute of Health Guide for the Care and Use
of Laboratory Animals (NIH publication number 80-23 revised
1996) and the Brazilian Society for Neuroscience and Behavior rec-
ommendations for animal care. The experimental protocols were
approved by the Oswaldo Cruz Foundation Committee of Ethics
for the Use of Animals (CEUA–Fiocruz) protocol number P-36/11-3.
2.3. Parasite strain and infection
L. amazonensis (MHOM/BR/75/JOSEFA) were maintained by reg-
ular passage in BALB/c mice. Amastigotes were puriﬁed from the
footpad lesions of mice as previously described (Barbieri et al.,
1993). Female BALB/c mice (6 weeks old) were obtained from Cen-
tro de Criação de Animais de Laboratório (CECAL)–Fiocruz, Rio de
Janeiro, RJ, Brazil, and injected subcutaneously in the right hind
footpad with 105 amastigotes (Arrais-Silva et al., 2006). Four
months post-infection the animals were euthanized, the brain cor-
tex was removed and maintained in liquid nitrogen until the
assays were performed. Additional groups of mice received a sys-
temic antioxidant therapy (N-acetylcysteine 20 mg/kg b.w., one
daily injection, i.p.) for ﬁve consecutive days before euthanasia.
During the post-infection period, animals show apathy and dimin-
ished eating behavior. To estimate parasite burden in the lesions,
the entire infected footpads were removed and amastigotes were
recovered from the lesions and counted. Inﬂammatory parameters
in liver and serum (TNF-a and IL-1b) were measured to conﬁrm
systemic inﬂammation. In all assays ﬁve animals per group
(n = 5) were utilized.
2.4. Antioxidant enzymes activities
Samples were homogenized in phosphate buffer (PB) 50 mM
(KH2PO4 and K2HPO4, pH-7.4) and the protein content was deter-
mined by Bradford method (Bradford, 1976). Catalase (CAT; E.C.
1.11.1.6) activity was evaluated by following the rate of decrease
in hydrogen peroxide (H2O2) absorbance in a spectrophotometer
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protein. The activity of superoxide dismutase (SOD; EC 1.15.1.1)
was measured by quantifying the inhibition of superoxide-depen-
dent adrenaline auto-oxidation in a sample buffer; adrenochrome
formation was monitored at 480 nm for 10 min (32 C) in a spec-
trophotometer (Misra and Fridovich, 1972). Results are expressed
as units of SOD/mg of protein.2.5. Oxidative damage to proteins (carbonyl)
As an index of protein oxidative damage, the carbonyl groups
were determined as previously described (Levine et al., 1990).
The homogenate were divided into two aliquots of 300 lL (1 mg
of protein). Proteins were precipitated by the addition of 150 lL
of 20% TCA for 5 min on ice and centrifuged at 4000g for 5 min.
The pellet was dissolved with 100 lL of sodium hydroxide (NaOH)
(200 mM) and 100 lL of hydrochloric acid (HCl) (2 M) was added
in blanks. DNPH (10 mM) was added for carbonyl groups derivati-
zation. Samples were maintained for 30 min at room temperature.
Proteins were precipitated with 20% TCA and washed three times
with 500 lL of 1:1 ethanol:ethyl acetate with 15 min standing
periods to remove the excess DNPH. Samples were dissolved in
200 lL of urea (8 M) pH 2.3, and the absorbance was read at
370 nm.2.6. Western blot detection of dinitrophenyl (DNP)-labeled protein
carbonyls
Tissue samples were homogenized in 1 volume of radio-immu-
noprecipitation assay (RIPA) buffer (20 mM Tris–HCl at pH 7.5,
150 mM NaCl, 1 mM Na2 EDTA, 1 mM EGTA, 1% NP-40, 1% sodium
deoxycholate, 2.5 mM sodium pyrophosphate, 1 mM b-glycero-
phosphate, 1 mM Na3VO4, 1 lg/mL leupeptin), centrifuged
(14,000g for 10 min at 4 C) and the pellet proteins were quanti-
ﬁed. Proteins were dissolved in 6% sodium dodecyl sulfate (SDS)
and derivatized with an equal volume of DNPH 10 mM in 10% tri-
ﬂuoroacetic acid for 1 h (Shacter et al., 1994). Samples were
subjected to SDS–polyacrylamide gel electrophoresis for Western
blot detection of DNP-derivatized proteins with an antibody
against DNP as described below.2.7. Sulfhydryl groups quantiﬁcation
Oxidative status of thiol groups were assessed by quantiﬁcation
of total reduced sulfhydryl (SH) groups in samples (Ellman, 1959).
Brieﬂy, for total SH content measurement, 60 lg sample aliquot
was diluted in phosphate-buffered saline (PBS) (NaCl, Na2HPO4,
KH2PO4), and 5,50-dithionitrobis 2-nitrobenzoic acid (10 mM),
and read in a spectrophotometer at 412 nm after 60 min of incuba-
tion in room temperature.2.8. Index of lipid peroxidation (TBARS)
The quantiﬁcation of thiobarbituric acid reactive substances
(TBARS) was performed for evaluation of an index of lipoperoxida-
tion, as previously described (Draper and Hadley, 1990). Brain
cortex tissue was homogenized in ice-cold Tris–HCl 15 mM (pH
7.4) and reacted with an equal volume of 40% trichloroacetic acid
(TCA), followed by centrifugation and addition of 0.67% TBA.
Samples were then incubated at 100 C for 25 min. After cooling,
samples were centrifuged (750g/10 min) and supernatant
absorbance was read at 535 nm.2.9. Total reactive antioxidant potential (TRAP assay)
The total reactive antioxidant potential (TRAP) was used as an
index of non-enzymatic antioxidant capacity. This assay is based
on the quenching of peroxyl radicals generated by AAPH (2,2 azo-
bis[2-amidinopropane]) by antioxidants present in a given sample
(Lissi et al., 1992). Brieﬂy, a chemical system that generates per-
oxyl radicals at a constant rate (an AAPH-containing buffer) is cou-
pled to a luminescent reactant (luminol) which emits photons
proportionally to its oxidation. The samples were homogenized
with glycine buffer (pH-8.6). The reaction was initiated by inject-
ing luminol to the 0.1 M glycine buffer containing AAPH that
resulted in steady luminescence emission. Equal amounts of sam-
ples are then added to this reaction system, and the luminescence
emission at the moment following this addition (t = 0) is recorded.
This initial emission reﬂects the production of free radicals by
AAPH at the ﬁrst moment right after sample addition and is related
to the endogenous oxidant state of the sample. Following incuba-
tion, the thermal decomposition of AAPH produces luminescence
at a constant rate (‘‘system’’), and the presence of free radical scav-
engers in the added sample will decrease this rate according to its
content of non-enzymatic antioxidants. We followed TRAP lumi-
nescence emission for 80 min and calculated the area under the
curve (AUC) relative to the system without samples (which was
considered as 100% of luminescence emission at all time points.
The addition of the homogenate samples decreases or facilitates
the luminescence emission proportionally to its redox state. The
luminescence emission was recorded in a MicroBeta lumines-
cence counter (Perkin Elmer, USA).
2.10. TNF-a, IL-1b, IFN-c, IL-6 and nitrotyrosine levels (ELISA)
TNF-a, IL-1b, IFN-c, IL-6 and nitrotyrosine were quantiﬁed by
indirect ELISA. Brain cortex homogenate was placed in ELISA
plates. After 24 h incubation, plates were washed three times with
Tween–Tris buffered saline (TTBS, 100 mM Tris–HCl, pH 7.5, con-
taining 0.9% NaCl, and 0.1% Tween-20). Subsequently, 200 lL of
anti-TNF-a, anti-IL-1b, anti-IFN-c, anti-IL-6 or anti-nitrotyrosine
(1:1000) were added and incubation was carried for 24 h at 4 C.
The plates were washed three times with TTBS and incubated with
rabbit or mouse IgG peroxidase-linked secondary antibody
(1:1000) for 2 h. After washing the plate three times with TTBS,
200 lL of substrate solution (TMB spectrophotometric ELISA detec-
tion kit) were added to each well and incubated for 15 min. The
reaction was terminated with 50 lL/well of 12 M sulfuric acid
stopping reagent and the plate read at 450 nm.
2.11. Immunoblot detection of phosphorylated tau and RAGE
To perform immunoblot experiments, the tissue was homogen-
ated with 1X RIPA buffer, centrifuged (10,000g for 5 min at 4 C)
and the pellet proteins were measured by the Bradford method
(Bradford, 1976). Laemmli-sample buffer (62.5 mM Tris–HCl, pH
6.8, 1% (w/v) SDS, 10% (v/v) glycerol) was added to complete vol-
ume according the protein content of each sample and equal
amounts of cell protein (30 lg/well) were fractionated by SDS–
PAGE and electro-blotted onto nitrocellulose membranes with
Trans-Blot SD Semi-Dry Electrophoretic Transfer Cell, Bio-Rad
(Hercules, CA, USA) . Protein loading and electro-blotting efﬁciency
were veriﬁed through Ponceau S staining, and the membrane was
washed with Tween–Tris buffered saline (Tris 100 mM, pH 7.5,
0.9% NaCl and 0.1% Tween-20). Membranes were incubated
20 min at room temperature in SNAP i.d. 2.0 Protein Detection
System Merck Millipore (Billerica, MA, USA) with each primary
antibody (anti-RAGE, anti-phospho-tau, anti-tau, anti-b-actin –
1:500 dilution range each) and then washed with TTBS. Anti-rabbit
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tion range) was incubated with membranes for additional 20 min
in SNAP i.d. system (Millipore, Billerica, MA, USA), washed again
and the immunoreactivity was detected by enhanced chemilumi-
nescence using Supersignal West Pico Chemiluminescent kit from
Thermo Scientiﬁc (Luminol/Enhancer and Stable Peroxide Buffer).
Densitometric analysis of the ﬁlms was performed with Image J.
software. Blots were developed to be linear in the range used for
densitometry.2.12. Statistical analysis
Statistical analysis was performed with GraphPad 5.0 software.
Student’s t test (two-tailed) was applied for simple comparisons
between control and infected animals in each assay. For
comparison of multiple means, ANOVA with Tukey’s post hoc
was performed. The results of measurements were expressed as
mean ± standard error of the mean (SEM). Differences were consid-
ered signiﬁcant when p < 0.05. The tissue protein content was
measured by Bradford method for data normalization in all assays
(Bradford, 1976).3. Results
Tau may be phosphorylated by diverse protein kinases at
approximately 25 different sites (Wang et al., 2013). However,
phosphorylation of tau on Ser396 is one of the earliest events lead-
ing to neuroﬁbrillary tangles formation in AD and Down syndrome
and it was suggested to play a key role in the formation of paired
helical ﬁlaments, the major component of neuroﬁbrillary tangles
(Mondragon-Rodriguez et al., 2014). We evaluated the content of
phosphorylated and total tau isoforms in the brain cortex of mice
infected by L. amazonensis by Western blot. An increase in the con-
tent of phospho-tau (Ser396) was detected, but the content of total
tau was not changed (Fig. 1A). This result indicates that tau phos-
phorylation in infected animals is increased by a mechanism that is
not associated with modulation of tau expression.
We next evaluated the immunocontent of RAGE in these sam-
ples of brain cortex. In animals infected by L. amazonensis, the total
content of RAGE was signiﬁcantly increased compared to control
animals (Fig. 1B). In AD, both tau aberrant phosphorylation and
RAGE up-regulation are strongly implicated in the molecular
mechanisms underlying the progression of neuronal death (Li
et al., 2012; Yan et al., 2009). RAGE has been suggested to be the
key component of the chronic pro-inﬂammatory axis responsibleFig. 1. Tau phosphorylation and RAGE content in brain cortex of mice infected with L. am
animals was removed and proteins were subjected to SDS–PAGE/Western blot analysis. (A
panel) and total tau (lower panel) from four control and four infected animals. Bar graph
samples. (B) Representative immunoblots of RAGE content from four control and four in
used as control for protein constitutive expression. Bar graph corresponds to mean ± S
depicted were obtained by applying two-tailed student’s t test.for microglia activation and reactive species production that
ultimately leads to neuronal cell death in AD and also in other neu-
rodegenerative processes (Maczurek et al., 2008). For this reason,
we next sought to evaluate parameters of inﬂammation and oxida-
tive/nitrosative stress in the brain cortex of mice infected with L.
amazonensis.
The levels of TNF-a and IL-1b were evaluated by ELISA. These
cytokines are considered markers of acute pro-inﬂammatory acti-
vation and have been associated with modulation of tau phosphor-
ylation and RAGE expression in some neuropathological states
(Krstic et al., 2012; Roe et al., 2011). Although an increase in
TNF-a levels was detected in other organs, such as liver (data not
shown), no signiﬁcant changes in the levels of both TNF-a and
IL-1b were detected in brain cortex of infected animals (Fig. 2A
and B). Thus, our results indicate that tau phosphorylation and
RAGE upregulation are not associated with TNF-a and IL-1b in
leishmaniasis.
We next evaluated parameters of oxidative and nitrosative
damage in biomolecules of brain cortex samples from mice
infected with L. amazonensis. We quantiﬁed levels of nitrotyrosine,
a marker of peroxynitrite-mediated protein nitration, in brain cor-
tex samples by ELISA. Besides, the quantiﬁcation of free (reduced)
thiol groups indicates the redox state of proteins and peptides con-
taining sulfhydryl groups that may undergo oxidation or reduction
and form disulﬁde bonds. No changes in the levels of nitrotyrosine
and free thiol groups were observed between control and infected
animals (Fig. 3A and B). On the other hand, the levels of TBARS
were signiﬁcantly increased in infected animals, suggesting an ele-
vated status of brain lipid peroxidation (Fig. 3C). Besides, the Wes-
tern blot analysis of DNP-reactive proteins indicated that protein
carbonylation in infected animals was increased (Fig. 3D), which
was also conﬁrmed by quantiﬁcation of carbonyl groups in the
samples (Fig. 3E).
The antioxidant status of brain cortex samples was also
analyzed. The activities of the antioxidant enzymes CAT and SOD
were measured. A decrease in CAT activity was observed in
infected animals, indicating impaired H2O2 detoxiﬁcation capacity
in brain cortex (Fig. 4A). SOD activity did not differ between control
and infected animals (Fig. 4B). Also, the analysis of the non-enzy-
matic antioxidant status by the TRAP assay showed that mice
infected by L. amazonensis had a decreased status in non-enzymatic
antioxidant defense, indicating a diminished antioxidant capacity
compared to control animals (Fig. 4C and D).
Finally, to verify whether tau phosphorylation was associated to
the elevated status of oxidative stress in the brain cortex, mice
infected with L. amazonensis were subjected to a daily i.p.azonensis. Four months after infection, brain cortex tissue from infected and control
) Representative immunoblots of tau phosphorylated at Ser396 (p-tau Ser396, upper
corresponds to mean ± SEM quantiﬁcation values of the p-tau/total tau ratio from all
fected animals (upper panel). Lower panel corresponds to b-actin immunocontent
EM quantiﬁcation values of the RAGE/b-actin ratio from all samples. Values for p
Fig. 2. Levels of TNF-a and IL-1b in brain cortex from mice infected with L. amazonensis. Four months after infection, brain cortex tissue from infected and control animals
was removed and proteins were subjected to ELISA detection of (A) TNF-a and (B) IL-1b internal levels. Values represent mean ± SEM of ﬁve samples from each group. No
statistical differences were detected using two-tailed student’s t test (for p = 0.005).
Fig. 3. Parameters of protein oxidative and nitrosative modiﬁcations in brain cortex from mice infected with L. amazonensis. (A) Protein samples from control and infected
animals were subjected to nitrotyrosine detection by ELISA. (B) Free thiol (sulfhydryl; SH) groups quantiﬁcation in brain cortex samples from control and infected animals. (C)
Quantiﬁcation of thiobarbituric acid reactive substances was performed as an index of lipoperoxidation. (D) Western blot detection of carbonyl groups was also performed by
analysis of total protein fraction of samples previously derivatized with DNP. Polyclonal anti-DNP was used to detect DNP-carbonyl derivatized proteins (upper gel panel) and
b-actin immunocontent used as control for protein constitutive expression (lower gel panel). Bar graph corresponds to mean ± SEM quantiﬁcation values of the DNP/b-actin
ratio from all samples. (E) Spectrophotometric quantiﬁcation of carbonyl groups was performed in the same samples. Bar graphs in A, B, C and E correspond to mean ± SEM
quantiﬁcation values from all samples. Values for p were obtained by applying two-tailed student’s t test and are shown only when p < 0.005.
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secutive days before euthanasia. Infected animals that received
NAC had decreased levels of phosphorylated tau compared to
infected animals that did not receive antioxidant therapy (Fig. 5A
and B), indicating a role for reactive species in tau phosphorylation.
Additionally, we compared the levels of IFN-c and IL-6, plus TNF-a
and IL-1b, between control and infected animals receiving NAC.
The levels of IFN-c were decreased in infected animals, while the
infected animals that received NAC recovered IFN-c levels to con-
trol values (Fig. 5C), which indicates a role for oxidative stress in
the modulation of IFN-c in the brain cortex of animals infected
with L. amazonensis. We did not observe any effect on IL-6 levels
at any group of animals (Fig. 5D). Besides, infected animals receiv-
ing NAC presented decreased TNF-a levels compared to infectedanimals that did not receive antioxidant therapy (Fig. 5E). No vari-
ations in IL-1b levels were observed in all groups (Fig. 5F).4. Discussion
Oxidative stress is an important factor in the course of Leish-
mania infection. L. amazonensis was reported to contain a cluster
of genes expressing META1 and META2 proteins, which were found
to be responsible for resistance of the parasite against heat shock
and oxidative stress (Ramos et al., 2011). These characteristics
probably evolved as a parasite’s strategy of resistance against the
oxidizing agents generated by inﬂammatory cells aimed to kill
intracellular and extracellular pathogens. However, depending on
Fig. 4. Antioxidant capacity in brain cortex samples from mice infected with L. amazonensis. The activities of antioxidant enzymes and the non-enzymatic antioxidant
potential in brain cortex samples from animals 4 months after infection were measured. (A) Catalase (CAT) activity. (B) Superoxide dismutase (SOD) activity. (C) Total reactive
antioxidant parameter (TRAP) kinetic assay; square dots represent control and circle dots represent samples from infected animals. (D) Quantiﬁcation of the area under the
curve between time points 0 min and 60 min of the kinetic assay (arbitrary units are shown). Bar graphs correspond to mean ± SEM quantiﬁcation values from all samples.
Values for p were obtained by applying two-tailed student’s t test and are shown only when p < 0.005.
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the host, the inﬂammatory response may be further intensiﬁed in
order to kill more resistant micro-organisms. The intensiﬁcation
of the production of oxidizing agents during this response may
affect cells and tissues of the host, thus contributing to further
development of the disease. The observation of oxidative damage
to proteins in the CNS of mice infected with L. amazonensis
reported here may bring new information for the understanding
of neurological symptoms in cutaneous leishmaniasis and related
parasitic infections. In previous studies, alterations in the redox
state of liver were observed only in visceral leishmaniasis caused
by infection of hamsters with Leishmania chagasi (Oliveira and
Cecchini, 2000).
Oxidative stress in patients and experimental models of leish-
maniasis is generally analyzed in the context of infected cells or
focusing on the microenvironment (tissue) of the injury. Granu-
lomatous inﬂammatory reaction is associated with the presence
of amastigotes within macrophages, reﬂecting in the function of
organs such as liver, spleen, lymph nodes and bone marrow. Cells
of the mononuclear phagocyte system are present in these organs
(Baneth and Aroch, 2008; Engwerda et al., 2004). In a previous
study conducted with the same animal model and infection proto-
col used here, it was observed that BALB/c mice infected with L.
amazonensis displayed inﬂammatory inﬁltrates of mononuclear
cells and neutrophils without parasites in the meninges and the
presence of macrophages containing parasites in the cerebral
parenchyma (Abreu-Silva et al., 2003). However, as observed in
studies with human subjects, the mere presence of parasites in
skin and draining lymph nodes (as in localized cutaneous leish-
maniosis) affects several neuroendocrine axes, and these effects
are believed to emerge as consequences of the actions of pro-
inﬂammatory factors released by peripheral tissues on the CNS
(Baccan et al., 2011).
Inﬂammation and oxidative stress are important components in
several neurodegenerative conditions. In AD and related tauopa-
thies, tau phosphorylation and RAGE up-regulation are unequivo-
cally stimulated. These characteristics are strongly believed to be
associated with the activation of RS production caused by factors
that sustain a chronic state of local inﬂammatory activation inCNS. However, we did not observe any changes in the levels of
TNF-a, IL-1b and IL-6 in the brain cortex of infected animals. These
cytokines are associated with acute inﬂammatory responses, while
RAGE is considered a marker of chronic pro-inﬂammatory develop-
ment (Ibrahim et al., 2013). TNF-a promotes the induction of IL-6
and IL-1b, and high levels of these cytokines in macrophages of rats
acutely infected with Leishmania braziliensis have been previously
reported (Brelaz-de-Castro et al., 2012). However, in leishmaniasis,
the action of these cytokines is more pronounced at either acute
phases or advanced stages of the chronic disease (Oliveira et al.,
2014). On the other hand, the levels of IFN-c were decreased in
the brain of infected animals, and the antioxidant therapy with
NAC recovered IFN-c status to control levels. IFN-c is associated
to the Th1 response, which is a necessary step of an adequate
immune response to control the parasite. A Th1 predominant
response is considered a good prognosis for control of the infection
with most species of Leishmania, while Th2-predominant response
is associated to the evolution of the disease (Pereira and Alves,
2008). Nonetheless, infections caused by L. amazonensis were
observed to downregulate IFN-c levels in lymph node cells to a
greater extent compared to other Leishmania species (Maioli
et al., 2004), and this was suggested to be part of a speciﬁc mech-
anism by which the parasite modulates the host immune system,
as INF-c-mediated induction of macrophage activation is essential
for control of the parasite (Alexander and Bryson, 2005). Inhibition
of IFN-c production in leishmaniasis is directly associated to
increased lesion size. The shift between Th1 and Th2 responses is
inﬂuenced in different ways by the parasite at earlier and later
stages of the disease, in order to couple the host immune response
with the progression of the parasite’s cycle and its change from
amastigote to promastigote forms (Pereira and Alves, 2008).
Interestingly, infected mice that received NAC presented
decreased TNF-a levels in the brain cortex compared to infected
animals that were not treated with NAC. Variations in the levels
of this cytokine were not observed between control and infected
animals, but the antioxidant treatment was able to reduce this
pro-inﬂammatory mediator in the brain of both control and
infected mice. At systemic level, an increase in IL-4 production
caused L. amazonensis promotes a Th2 response and downregulates
Fig. 5. Effects of antioxidant therapy with NAC in tau phosphorylation and brain cortex cytokines. Uninfected and infected animals were subdivided into groups that received
one daily i.p. injection of N-acetylcysteine (NAC) 20 mg/kg for ﬁve consecutive days before the day of euthanasia. (A) Representative Western blots of brain cortex samples
incubated with antibodies to tau phosphorylated at Ser396 (p-tau Ser396, upper panel) and total tau (lower panel). (B) Mean ± SEM quantiﬁcation values of the p-tau/total tau
ratio from all samples. Relative quantiﬁcation of cytokine levels was assessed by ELISA in samples from the same groups. (C) IFN-c, (D) IL-6, (E) TNF-a and (F) IL-1b levels
were analyzed. Values represent mean ± SEM of all samples from each group. ANOVA with Tukey’s post hoc analysis was performed. * denotes difference from control group;
# denotes difference from infected group (p = 0.005).
J. Gasparotto et al. / Brain, Behavior, and Immunity 43 (2015) 37–45 43IFN-c production. These effects are believed to be directly related
to the decrease of macrophage activation and TNF-a production
associated to the progression of leishmaniasis, as these events
would be a consequence of the shift from Th1 to Th2 response
caused by the parasite (Pereira and Alves, 2008). Thus, it is surpris-
ing that TNF-a levels are not decreased along with IFN-c in
infected animals. However, the changes in the levels of these cyto-
kines caused by NAC treatment suggest that redox-dependent
mechanisms are a key factor in the regulation of pro-inﬂammatory
mediators at CNs level in leishmaniasis. It is possible that the pro-
oxidant environment in the brain cortex of infected animals is
responsible for maintaining TNF-a levels unaltered compared to
control animals, instead of an expected decrease in the levels of
this cytokine, since Th1 response is supposed to be suppressed.
In AD, accumulated evidence shows that stimulation of the
amyloidogenic pathway results in the activation of innate immune
system mainly by pattern recognition receptors (PRRs), including
RAGE (Salminen et al., 2009). In the amyloidogenic pathway,
beta-amyloid peptide release in CNS stimulates oligomers and
ﬁbril accumulation (early steps of amyloid plaques formation),
which may act as danger-associated molecular patterns (DAMPs).DAMPs stimulate the up-regulation and activation of PRRs such
as Toll-like receptors, NOD-like receptors and RAGE (Maczurek
et al., 2008; Salminen et al., 2009). RAGE activation, in turn,
triggers a wide array of cellular responses relevant to neurodegen-
erative progression in AD, such as the transcriptional activation of
NF-kB-regulated genes (which include several genes associated
with pro-inﬂammatory activation, oxidative stress and cell sur-
vival-associated responses), MAPK activation (which regulates
both cell survival/death responses as well as inﬂammatory activa-
tion) and NADPH oxidase activation (which leads to microglia
recruitment/activation, increased RS production and modulation
of redox-sensitive protein kinases and transcription factors)
(Arancio et al., 2004; Kojro and Postina, 2009; Maczurek et al.,
2008; Sims et al., 2010; Yan et al., 2009).
Oxidative stress-related protein carbonylation, nitrotyrosina-
tion and thiol oxidation favor the formation of intra- and
intermolecular protein cross-links, which leads to conformational
changes increasing hydrophobicity and aggregation. These oxida-
tive alterations favor the formation of protein cross-links, inducing
generalized cellular dysfunction (Halliwell, 2006). Although we did
not detect changes in thiol oxidation or nitrotyrosine formation
44 J. Gasparotto et al. / Brain, Behavior, and Immunity 43 (2015) 37–45here, protein carbonylation was signiﬁcantly increased in infected
animals. This oxidative modiﬁcation is responsible for the impair-
ment in several protein functions by causing disruption of proteos-
somic-mediated protein turnover and generation of aberrant
conformations (Kastle and Grune, 2011). We also observed that
the non-enzymatic antioxidant potential in the brain cortex of
infected animals was decreased, suggesting a state of enhanced
RS production. These observations, altogether, strongly suggest
that the increase in tau phosphorylation and RAGE protein content
in the brain cortex of animals infected with L. amazonensis is asso-
ciated with a state of oxidative stress in the CNS caused by the
infection. It is possible brain oxidative stress may be a sustained
response to acute pro-inﬂammatory activation induced in early
stages of the infection, contributing later to the evolution of the
chronic disease. Also, as previously stated, it is important to note
that even when the presence of the parasite within the CNS is
not certain, Leishmania spp. infection have been reported by differ-
ent works to exert neurologic effects as consequence of systemic
alterations originated by local inﬂammatory responses in organs
such as liver and spleen (Melo et al., 2013; Petersen and
Greenlee, 2011). In human patients with localized cutaneous leish-
maniasis, plasma levels of cortisol, estradiol or prolactin positively
correlated with at least one clinical parameter of the disease
(lesion size, dose used to reach cure and time to cure), indicating
a reﬂect in neuroendocrine regulation (Baccan et al., 2011). It is
possible that such modiﬁcations may contribute to brain oxidative
stress, since neuroendocrine hormones may exert signiﬁcant
changes in the redox state of the CNS (Mancini et al., 2010).
It is reasonable to suggest, based on our present data, that the
increase in tau phosphorylation and RAGE immunocontent is a
consequence of the oxidative stress in brain cortex. Tau phosphor-
ylation and RAGE expression have been previously observed to be
regulated by pro-inﬂammatory cytokines, including TNF-a and IL-
1 (Li et al., 2003; Shi et al., 2011). We observed that levels of TNF-a
in infected animals treated with NAC are decreased compared to
infected animals that were not treated with NAC. These data indi-
cate that a participation of TNF-a in the induction of tau aberrant
phosphorylation may not be completely ruled out. On the other
hand, we must consider that the decrease in IFN-c levels could
be involved in this effect, as the levels of this cytokine were recov-
ered in infected animals subjected to antioxidant treatment. The
inhibitory effect of NAC treatment on tau phosphorylation was
very clear in our experimental model. These data, altogether with
the effects observed other cytokines with NAC treatment, strongly
suggests that aberrant tau phosphorylation is caused primarily by
a redox-dependent mechanism in the brain of animals infected
with L. amazonensis.
Several evidence associate increased RS production and oxida-
tive damage to biomolecules to both tau aberrant phosphorylation
and RAGE up-regulation/activation (de Bittencourt Pasquali et al.,
2013; Mondragon-Rodriguez et al., 2014, 2013). In AD, there is a
clear role of oxidative stress in the progression of neurodegenera-
tion, and both tau phosphorylation and aggregation are involved in
RS-dependent neuronal death in the course of the disease (Schmitt
et al., 2012). RAGE up-regulation in response to oxidative stress
was observed in different diseases where increased RS production
is a characteristic, including diabetes, atherosclerosis and AD (Guo
et al., 2008; Kojro and Postina, 2009). In AD, RAGE is believed to
contribute in maintaining an elevated state of RS production by
stimulating NADPH oxidase (Kojro and Postina, 2009), enhance
tau phosphorylation via the ERK1/2-GSK3b pathway (Barroso
et al., 2013; Li et al., 2012) and amyloid translocation through
blood–brain barrier (Candela et al., 2010). In this context, it is
possible that neurologic symptoms associated with chronic leish-
maniasis are related to disruptions in the homeostasis of CNS pro-
teins, such as tau and RAGE, as consequence of oxidative stresswhich in turn may be originated initially by systemic infection.
This is the ﬁrst demonstration of alterations in biochemical param-
eters of neurodegeneration in an experimental model of Leishmania
infection. The relationship between the regulation of RAGE expres-
sion and function in the course of leishmaniasis and its relationship
with modulation of Th1/Th2 responses arises from this work as an
interesting issue to be addressed in future studies.
This was an exploratory study and, as such, more detailed eval-
uations aiming to understand mechanistic relationships or propose
intervention procedures could not be performed at this stage.
Therefore, it is important to point some limitations inherent to this
study. First, although data presented here strongly indicate an
association of oxidative stress with modulation of tau phosphory-
lation and RAGE in leishmaniasis, this relationship would only be
fully established if administration of antioxidants is able to reverse
the effects of L. amazonensis infection on these parameters. Also,
we did not explore the full complexity of the inﬂammatory
response, as we focused on biochemical parameters more com-
monly observed in inﬂammatory diseases of the CNS and in neuro-
degenerative conditions. Thus, the absence of increase in TNF-a
and IL-1b levels do not necessarily mean absence of brain inﬂam-
mation. A detailed study focused on a longitudinal evaluation of
neurological, neurodegenerative and pro/anti-inﬂammatory
parameters (including a wider range of Th1/Th2 mediators) must
be performed for a full comprehension of the mechanisms involved
in the etiology of CNS damage in leishmaniasis. Nonetheless, this is
the ﬁrst observation of classic neurodegenerative parameters in
this disease, which is not only clinically relevant as it also opens
perspectives of new mechanistic and intervention studies.Acknowledgements
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